Last 17 quarters of trend data · Healthcare · Medical - Healthcare Information Services
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
GE HealthCare Technologies Inc.'s quarterly P/E stands at 20.9x, up 27.6% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has expanded 34.7% YoY to 19.3x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 13.54 | 20.94 | 53.96 | 19.16 | 17.47 | 16.40 | 12.45 | 23.00 | 20.95 | 28.06 | 21.97 | 20.74 | 22.32 |
| — | +27.6% | +333.5% | -16.7% | -16.6% | -41.5% | -43.3% | +10.9% | -6.1% | -43.9% | +83.6% | — | — | |
| P/S Ratio | 1.36 | 1.58 | 2.02 | 1.67 | 1.69 | 1.94 | 1.69 | 2.21 | 1.85 | 2.24 | 1.70 | 1.62 | 1.93 |
| — | -18.3% | +19.7% | -24.7% | -8.3% | -13.6% | -0.8% | +37.1% | -4.3% | +12.7% | +26.8% | — | — | |
| P/B Ratio | 2.67 | 2.98 | 3.56 | 3.36 | 3.41 | 3.93 | 4.15 | 5.06 | 4.47 | 5.49 | 4.84 | 4.27 | 5.08 |
| — | -24.1% | -14.1% | -33.6% | -23.8% | -28.4% | -14.4% | +18.6% | -11.9% | +1.0% | +75.3% | — | — | |
| P/FCF | 18.60 | 72.61 | 10.29 | 17.76 | 1060.13 | 94.50 | 11.06 | 16.62 | — | 38.07 | 9.26 | 13.67 | — |
| — | -23.2% | -7.0% | +6.9% | — | +148.2% | +19.5% | +21.6% | — | +32.0% | +34.9% | — | — | |
| EV / EBITDA | 10.03 | 19.26 | 8.92 | 12.82 | 12.78 | 14.30 | 11.26 | 15.34 | 14.34 | 17.74 | 12.84 | 12.66 | 15.67 |
| — | +34.7% | -20.8% | -16.4% | -10.8% | -19.4% | -12.3% | +21.1% | -8.5% | +11.9% | +42.3% | — | — | |
| EV / EBIT | 12.13 | 19.26 | 34.10 | 13.61 | 14.12 | 13.62 | 11.21 | 15.94 | 15.31 | 18.78 | 14.16 | 12.60 | 16.44 |
| — | +41.3% | +204.2% | -14.6% | -7.8% | -27.5% | -20.9% | +26.5% | -6.9% | +12.9% | +30.8% | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
GE HealthCare Technologies Inc.'s operating margin was 10.0% in Q1 2026, down 4.2 pp QoQ and down 3.1 pp YoY. The trailing four-quarter average of 12.5% exceeds the current quarter, suggesting the latest result may reflect seasonal weakness or a one-off headwind. Gross margin contracted 8.5% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.0% | 38.5% | 54.3% | 38.7% | 39.7% | 42.1% | 42.8% | 41.7% | 41.4% | 40.9% | 41.4% | 40.1% | 40.3% |
| — | -8.5% | +27.0% | -7.1% | -4.2% | +3.0% | +3.3% | +3.8% | +2.7% | +1.8% | +5.8% | +3.9% | -0.7% | |
| Operating Margin | 13.4% | 10.0% | 14.2% | 12.7% | 13.1% | 13.2% | 15.1% | 13.9% | 12.6% | 11.6% | 13.2% | 12.8% | 11.8% |
| — | -23.8% | -5.7% | -8.7% | +4.0% | +13.4% | +13.8% | +8.6% | +6.2% | -2.2% | -15.9% | +9.2% | -25.3% | |
| Net Margin | 10.1% | 7.6% | 3.9% | 8.7% | 9.7% | 11.8% | 13.5% | 9.7% | 8.8% | 8.0% | 7.7% | 7.8% | 8.7% |
| — | -35.8% | -70.9% | -10.5% | +9.8% | +46.8% | +74.9% | +24.5% | +1.9% | +1.8% | -31.0% | -13.2% | -29.4% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 21.6% | 3.6% | 1.8% | 4.4% | 5.0% | 6.2% | 8.4% | 5.7% | 5.5% | 5.0% | 5.5% | 5.1% | 5.9% |
| — | -42.0% | -78.9% | -22.5% | -8.6% | +24.4% | +52.1% | +11.3% | -6.6% | +11.2% | -4.5% | +122.7% | +66.1% | |
| ROA | 6.0% | 1.1% | 0.5% | 1.2% | 1.4% | 1.7% | 2.2% | 1.4% | 1.3% | 1.2% | 1.2% | 1.2% | 1.3% |
| — | -37.9% | -76.6% | -13.1% | +5.3% | +46.2% | +73.0% | +23.7% | +3.8% | -6.4% | -38.2% | -35.6% | -52.9% | |
| ROIC | 13.3% | 2.2% | 3.0% | 2.9% | 3.0% | 3.0% | 3.9% | 3.2% | 3.0% | 2.8% | 3.5% | 3.0% | 2.8% |
| — | -27.4% | -22.7% | -11.0% | -1.6% | +9.4% | +12.5% | +7.6% | +7.0% | +3.9% | -0.2% | +32.7% | -18.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
GE HealthCare Technologies Inc.'s Debt/EBITDA ratio is 20.0x, up from 8.3x last quarter — elevated, raising questions about debt serviceability. The current ratio has improved 24.4% YoY to 1.17x, strengthening the short-term liquidity position.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.94 | 0.97 | 0.94 | 1.05 | 1.09 | 0.98 | 1.08 | 1.26 | 1.21 | 1.27 | 1.35 | 1.40 | 1.40 |
| — | -0.5% | -12.9% | -16.6% | -9.9% | -23.4% | -19.7% | -10.2% | -13.5% | -14.3% | +49.9% | — | +5305.4% | |
| Debt / EBITDA | 2.99 | 19.96 | 8.25 | 13.41 | 13.52 | 12.01 | 9.96 | 13.11 | 12.76 | 14.05 | 11.84 | 13.32 | 14.10 |
| — | +66.2% | -17.2% | +2.4% | +5.9% | -14.6% | -15.8% | -1.6% | -9.5% | -1.7% | +28.1% | — | +2743.0% | |
| Current Ratio | 1.18 | 1.17 | 1.18 | 1.18 | 1.12 | 0.94 | 1.00 | 1.19 | 1.01 | 1.01 | 1.00 | 1.20 | 1.17 |
| — | +24.4% | +18.0% | -0.4% | +10.4% | -7.3% | -0.7% | -1.2% | -13.0% | -9.3% | -7.7% | — | +20.5% | |
| Quick Ratio | 0.93 | 0.89 | 0.93 | 0.95 | 0.89 | 0.72 | 0.79 | 0.94 | 0.77 | 0.79 | 0.78 | 0.92 | 0.87 |
| — | +23.5% | +17.2% | +1.2% | +14.8% | -8.4% | +1.0% | +2.3% | -11.1% | -6.5% | -0.3% | — | +27.5% | |
| Interest Coverage | 7.13 | 5.52 | 3.08 | 6.13 | 6.42 | 7.23 | 8.51 | 6.06 | 5.41 | 4.71 | 5.76 | 5.61 | 5.05 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 17 years · Updated daily
Deep dive into GEHC consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying GEHC stock.
GE HealthCare Technologies Inc.'s current P/E is 13.5x. The average P/E over the last 4 quarters is 27.9x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
GE HealthCare Technologies Inc.'s current operating margin is 13.4%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking GE HealthCare Technologies Inc.'s business trajectory between earnings reports.